MedPath

Study of efficacy and safety of KSM-66 Ashwagandhaa (Withania somnifera Dunal) in stress and anxiety and on general well being in healthy adults.

Phase 1
Completed
Registration Number
CTRI/2011/091/000222
Lead Sponsor
Ixoreal Biomed Priavte Limited,#5-9-225, 3rd floor, Sanali estate, Chirag ali lane, Abids,Hyderabad, Andhra Pradesh- 500001, India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

?Healthy adults of either sex, who are facing routine work stresses, who sign the Informed Consent Form.
?Age group 18 -54 years
?Can read , write and understand English
?Subjects with WHO-5 well being index < 15 or PSS scores >14

Exclusion Criteria

?Suffering from any chronic physical, hormonal or psychiatric illness
?Current substance dependence
?Individuals refusing to use appropriate non-hormonal birth control measures.
?Pregnancy / lactating mothers
?Currently taking any other medication on a regular basis
?Currently taking any herbal preparations (other formulations containing ashwagandha / ginseng / ginkgo biloba / brahmi etc)
?Clinically significant findings on laboratory investigations and ECG

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total score on DASS and GHQ-28 after 8 wkTimepoint: 0 day, 60 day
Secondary Outcome Measures
NameTimeMethod
Comparison of the study and control group on PSS scores<br>Comparison of the study and control groups on various laboratory measures and serum cortisol levels<br>Comparison of the study and control group on PSS scores<br>Comparison of the study and control groups on various laboratory measures and serum cortisol levels<br>Timepoint: 0 day and 60 day
© Copyright 2025. All Rights Reserved by MedPath